Dialysis Drug OK'd for Marketing

(MedPage Today) -- A new phosphate binder has been cleared to treat hyperphosphatemia in chronic kidney disease (CKD) patients on dialysis, drugmaker Keryx Pharmaceuticals announced.
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news